Trevi Therapeutics Inc. (TRVI)
NASDAQ: TRVI
· Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT
Trevi Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 146K | 146K | 146K | 176K | 176K | 176K | 176K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 111K | 111K | 109K | 144K | 143K | 139K | 123K | 103K | 77K | 51K | 43K | 40K | 44K | 48K | 50K | 38K | 25K | 13K |
Gross Profit | -38K | -38K | -36K | 32K | 33K | 37K | 53K | -103K | -77K | -51K | -43K | -40K | -44K | -48K | -50K | -38K | -25K | -13K |
Operating Income | -51.52M | -51.09M | -51.52M | -48.22M | -43.17M | -38.27M | -33.92M | -31.65M | -31.01M | -30.44M | -29.91M | -31.52M | -30.07M | -31.41M | -32.48M | -33.4M | -33.69M | -31.94M |
Interest Income | 4.2M | 3.73M | 3.6M | 3.9M | 4.25M | 4.53M | 4.75M | 4.73M | 3.97M | 2.96M | 1.74M | 626K | 204K | 11K | 10K | 11K | 12K | 24K |
Pretax Income | -47.34M | -47.38M | -47.94M | -44.35M | -38.78M | -33.6M | -29.1M | -26.82M | -27.38M | -28.26M | -29.19M | -32.19M | -31.17M | -32.91M | -33.96M | -34.94M | -35.08M | -32.68M |
Net Income | -47.3M | -47.35M | -47.91M | -44.32M | -38.77M | -33.57M | -29.07M | -26.75M | -27.32M | -28.22M | -29.15M | -32.17M | -31.16M | -32.9M | -33.94M | -34.94M | -35.07M | -32.66M |
Selling & General & Admin | 13.77M | 12.67M | 12.07M | 11.54M | 11.4M | 10.71M | 10.21M | 10.16M | 10.08M | 10.26M | 10.07M | 9.83M | 9.42M | 9.37M | 9.49M | 10.03M | 10.22M | 10.04M |
Research & Development | 37.75M | 38.38M | 39.38M | 36.57M | 31.67M | 27.49M | 23.68M | 21.48M | 20.93M | 20.19M | 19.83M | 21.7M | 20.64M | 22.04M | 22.98M | 23.36M | 23.48M | 21.9M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 51.52M | 51.05M | 51.45M | 48.11M | 43.06M | 38.2M | 33.89M | 31.65M | 31.01M | 30.44M | 29.91M | 31.52M | 30.07M | 31.41M | 32.48M | 33.4M | 33.69M | 31.94M |
Interest Expense | 2K | 3K | 4K | 7K | 9K | 159K | 389K | 659K | 948K | 1.09M | 1.16M | 1.2M | 1.21M | 1.21M | 1.2M | 1.2M | 1.05M | 750K |
Selling & Marketing Expenses | n/a | -38K | -73K | -108K | -108K | -70K | -35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 51.52M | 51.09M | 51.52M | 48.22M | 43.17M | 38.27M | 33.92M | 31.65M | 31.01M | 30.44M | 29.91M | 31.52M | 30.07M | 31.41M | 32.48M | 33.4M | 33.69M | 31.94M |
Income Tax Expense | -47K | -34K | -31K | -29K | -11K | -33K | -32K | -70K | -64K | -38K | -36K | -22K | -13K | -11K | -21K | 2K | -11K | -24K |
Shares Outstanding (Basic) | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M | 98.61M | 98.13M | 68.9M | 59.54M | 30.81M | 21.61M | 21.61M | 20.12M | 19.42M |
Shares Outstanding (Diluted) | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M | 98.61M | 98.13M | 68.9M | 59.54M | 30.81M | 21.61M | 21.61M | 20.12M | 19.42M |
EPS (Basic) | -0.42 | -0.45 | -0.47 | -0.44 | -0.39 | -0.34 | -0.29 | -0.27 | -0.31 | -0.38 | -0.56 | -0.89 | -1.11 | -1.46 | -1.65 | -1.77 | -1.84 | -1.76 |
EPS (Diluted) | -0.42 | -0.45 | -0.47 | -0.44 | -0.39 | -0.34 | -0.29 | -0.27 | -0.31 | -0.38 | -0.56 | -0.89 | -1.11 | -1.46 | -1.65 | -1.77 | -1.84 | -1.76 |
EBITDA | -49.79M | -48.39M | -47.79M | -44.2M | -38.63M | -33.3M | -28.58M | -26.05M | -26.35M | -27.12M | -27.98M | -30.95M | -29.92M | -31.65M | -32.71M | -33.69M | -33.98M | -31.88M |
EBIT | -47.34M | -47.38M | -47.94M | -44.34M | -38.77M | -33.44M | -28.71M | -26.16M | -26.43M | -27.17M | -28.02M | -30.99M | -29.96M | -31.7M | -32.76M | -33.74M | -34.03M | -31.93M |
Depreciation & Amortization | 111K | 149K | 147K | 144K | 143K | 139K | 123K | 103K | 77K | 51K | 43K | 40K | 44K | 48K | 50K | 51K | 51K | 50K |